… spent $30.2 billion on specialty autoimmune medicines like Rasuvo, Humira, and Enbrel in 2015, according to IMS Health, and spending on autoimmune treatments grew 28% from the prior year-more quickly than any other treatment category. Koios’s …
Category: Rheumatrex, Methotrexate (generic)
Koios Pharmaceuticals Receives Favorable Ruling in Challenge to High-Cost Druga s Patent
… spent $30.2 billion on specialty autoimmune medicines like Rasuvo, Humira, and Enbrel in 2015, according to IMS Health, and spending on autoimmune treatments grew 28% from the prior year-more quickly than any other treatment category. Koios’s …
Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report
Phanerochaete sordida is a species of wood rotting fungus, which can degrade lignin, cellulose and hemicellulose contained in wood and other hard-to-biodegrade organic substances. However, to date, there have been no other reports demonstrating that P. sordida can infect humans.
Positive Results Reported for Potential Humira Biosimilar
The comparative, confirmatory REFLECTIONS B538-02 study has met its primary objective by demonstrating equivalent efficacy, as measured by the American College of Rheumatology 20 response rate at week 12, between PF-06410293 and Humira . PF-06410293, a monoclonal antibody, is being developed as a potential biosimilar to Humira.
Antares Pharma: Drug Delivery To Multiple Fronts Of Profitability
… growing for some time as patients can administer injections at home for routine medications without having to go to a health professional. The devices above offer a pre-filled, disposable dosage of drugs that allow maximum bioavailability as drugs …